Physical and functional interaction between p53 mutants and different isoforms of p73

Sabrina Strano, Eliana Munarriz, Mario Rossi, Barbara Cristofanelli, Yosef Shaul, Luisa Castagnoli, Arnold J. Levine, Ada Sacchi, Gianni Cesareni, Moshe Oren, Giovanni Blandino

Research output: Contribution to journalArticlepeer-review


p53 is the most frequently inactivated tumor suppressor gene in human cancer, whereas its homologue, p73, is rarely mutated. Similarly to p53, p73 can promote growth arrest or apoptosis when overexpressed in certain p53-null tumor cells. It has previously been shown that some human tumor-derived p53 mutants can exert gain of function activity. The molecular mechanism underlying this activity remains to be elucidated. We show here that human tumor-derived p53 mutants (p53His175 and p53Gly281) associate in vitro and in vivo with p73α, β, γ, and δ. This association occurs under physiological conditions, as verified in T47D and SKBR3 breast cancer cell lines. The core domain of mutant p53 is sufficient for the association with p73, whereas both the specific DNA binding and the oligomerization domains of p73 are required for the association with mutant p53. Furthermore, p53His175 and p53Gly281 mutants markedly reduce the transcriptional activity of the various isoforms of p73. Thus, human tumor-derived p53 mutants can associate with p73 not only physically but also functionally. These findings define a network involving mutant p53 and the various spliced isoforms of p73 that may confer upon tumor cells a selective survival advantage.

Original languageEnglish
Pages (from-to)29503-29512
Number of pages10
JournalJournal of Biological Chemistry
Issue number38
Publication statusPublished - Sep 22 2000

ASJC Scopus subject areas

  • Biochemistry


Dive into the research topics of 'Physical and functional interaction between p53 mutants and different isoforms of p73'. Together they form a unique fingerprint.

Cite this